Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Multilevel factors shaping blinatumomab delivery across diverse LMICs
Multilevel factors shaping blinatumomab delivery across diverse LMICs

ASCO: Trial compares common adjuvant treatments for pancreatic cancer

Dr. John Neoptolemos - University of Liverpool, Liverpool, UK
ASCO: Trial compares common adjuvant treatments for pancreatic cancer ( Dr. John Neoptolemos - University of Liverpool, Liverpool, UK )
18 Jun 2009

ASCO: Pemetrexed extends survival as maintenance therapy

Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA
ASCO: Pemetrexed extends survival as maintenance therapy ( Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA )
18 Jun 2009

ASCO: Oxaliplatin does not improve outcomes for rectal cancer

Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy
ASCO: Oxaliplatin does not improve outcomes for rectal cancer ( Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy )
18 Jun 2009

Oestrogen and progestin therapy increases NSCLC risk

Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
Oestrogen and progestin therapy increases NSCLC risk ( Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US )
17 Jun 2009

ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC

Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC ( Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US )
17 Jun 2009

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer

Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )
17 Jun 2009

AACR 2009: Circulating tumour cells as biomarkers

Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009

NHS health care and the US health system

Exclusive interview with Professor Karol Sikora - Medical Director of Cancer Partners UK
NHS health care and the US health system ( Exclusive interview with Professor Karol Sikora - Medical Director of Cancer Partners UK )
28 May 2009

AACR 2009: Tackling the p53 gene and side effects

Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation